arly complete recanalization of an occluded artery is a strong predictor of favorable functional outcome in patients with acute ischemic stroke.
perviousness by measurement of the attenuation increase, induced by contrast penetration into the thrombus, with combined noncontrast computed tomography (NCCT) and CT angiography (CTA). 7 We hypothesize that thrombus perviousness, as measured on baseline imaging, improves intravenous r-tPA treatment efficacy and more often results in complete recanalization.
Methods

Patient Imaging
Patient image and clinical data were retrospectively selected from the Dutch Acute Stroke Study (DUST) (n=1393), a prospective multicenter cohort study in patients with a clinical diagnosis of acute ischemic stroke who underwent CT scanning within 9 hours after the symptom onset. 8 Patients with a proven proximal occlusion of the anterior or posterior circulation on CTA (n=671) were selected for the current substudy. Baseline reconstructed NCCT and CTA had to be performed on the same type of scanner and with slice thickness of <2.5 mm. Nonobligatory follow-up CTA was performed together with nonobligatory follow-up NCCT at 3 days (±2 days) after admission and in case of clinical deterioration. Three hundred sixty-four patients were excluded because of image quality limitations, resulting in 308 patients who were finally included in this study. For 124 patients, no follow-up images were available, and the recanalization could not be assessed. The flow chart and details of exclusion are presented in Figure I in the online-only Data Supplement and the image acquisition information is presented in Table I in the online-only Data Supplement.
Ethical approval was obtained from the medical ethics committee of the University Medical Center Utrecht, The Netherlands, in addition to local approval from all participating hospitals. Informed consent was obtained from all patients or their legal representatives. The medical ethics committee waived the need for informed consent for patients who died before informed consent could be obtained.
Thrombus Perviousness Assessment
The perviousness measurement aims to quantify possible contrast penetrating the thrombus. 7 The measurements were performed by manually placing 3 spherical regions of interest with a radius of 1 mm within the thrombus on coregistered and simultaneously displayed CTA and NCCT images ( Figure 1 ). CTA images were automatically aligned with NCCT images using a rigid registration with the open source software Elastix. 9 If the alignment was suboptimal, a correction was performed using manual rigid registration tools available in Mevislab. 10 Subsequently, the average of the regions of interest was used as the mean attenuation. Thereafter, the CTA thrombus attenuation increase (TAI), which is the increase of the mean attenuation in the thrombus on CTA compared with NCCT, was calculated. The measurements were performed by 1 of 2 raters (E.M.M.S. or K.M.T.). An expert rater (C.B.M.) assessed those patients in whom the other raters were unable to perform density assessment, for example, because of a mediocre image quality or difficulty in locating the occlusion. The raters had access to the coregistered baseline NCCT and CTA images during the measurement and the reported occlusion locations. All raters were blinded from all other clinical data and the measured attenuations.
Recanalization
Follow-up CTA was used to evaluate dissolution of the thrombus. Complete recanalization was defined as revascularization of the primary occlusion and all arteries distal to the primary occlusion. The assessment of the flow and complete recanalization status was performed by 3 observers with >5 years of stroke imaging experience (J.W. Dankbaar, I.C. van der Schaaf, and B.K. Velthuis), who were blinded from clinical and imaging data except the side of the neurological symptoms.
Statistical Analysis
We tested the association of perviousness with intravenous r-tPA treatment success by performing univariate and multivariate logistic regressions. Complete recanalization assessed on follow-up CTA was the primary outcome measure. Favorable functional outcome (modified Rankin Scale [mRS] score of ≤2 at 90 days) was used as a secondary outcome measure.
For the multivariate models, associations of baseline imaging and clinical characteristics with the primary outcome measure and with perviousness were assessed. Normality of all continuous variables was assessed using the Shapiro-Wilk test. Continuous normally distributed data were presented as means with their SD. Continuous not normally distributed data were presented as medians and the interquartile range. Categorical and ordinal data were presented using counts and proportions. Baseline characteristics were presented for the entire data set and for treatment subgroups. Differences in TAI per categorical baseline characteristic were assessed using unpaired Mann-Whitney tests. Similarly, associations of TAI with ordinal variables were investigated using a 1-way Kruskal-Wallis ANOVA. Correlations of TAI with other continuous determinants were assessed by the calculation of the Spearman correlation coefficient. Outliers of the normalized TAI were excluded using the Tukey Hinges method after a log transformation of TAI to make it normally distributed. 11 For the remainder of the article, only the original TAI 
Association of TAI With Complete Recanalization
To study the treatment modification effect of thrombus perviousness on the efficacy of intravenous r-tPA, we performed univariate and multivariate logistic regressions. To assess this modification effect, patients with intra-arterial treatment (IAT; n=16) and the 2 outliers were excluded leaving patients treated only with intravenous r-tPA (n=110) and without treatment (n=58) ( Figure I in the online-only Data Supplement). The odds ratio (OR) of complete recanalization for intravenous r-tPA was calculated using univariate logistic regression. Similarly, we determined the ORs of complete recanalization per unit increase of TAI. Subsequently, the ORs of complete recanalization for TAI and for intravenous r-tPA were estimated with a multivariate logistic regression model. In this model, we included TAI and intravenous r-tPA and their multiplicative interaction term to test for interaction of TAI on the intravenous r-tPA treatment effect.
Association of Dichotomized TAI With Complete Recanalization
To optimally dichotomize thrombi as pervious or impervious, a 2-graph receiver operating characteristic analysis was performed to determine a threshold for TAI in the intravenous r-tPA treatment group that optimizes sensitivity and specificity of complete recanalization. 12 Subsequently, the OR for a complete recanalization for dichotomized perviousness in the intravenous group was calculated using univariate logistic regression. Adjusted ORs (aOR) were calculated in a multivariate model including clinical and imaging baseline characteristics that were associated with complete recanalization with P<0.1.
Association of Dichotomized TAI With Functional Outcome
To evaluate whether thrombus perviousness is also associated with improved functional outcome, we performed univariate and multivariate logistic regressions to associate dichotomized TAI with favorable functional outcome (mRS score of ≤2) as outcome measure. This test was performed for the entire data set of patients without the 2 outliers (n=306). The ORs of favorable outcome for intravenous r-tPA treated versus conservative treatment was assessed using univariate logistic regressions, and similarly for pervious versus impervious thrombus. To determine whether perviousness is independently associated with functional outcome in a model that includes recanalization, aORs were calculated in a multivariate logistic regression model including perviousness and recanalization status for the total population and for each treatment group separately.
Results
Baseline, imaging, and outcome characteristics descriptive analysis and their associations with TAI and complete recanalization are presented in Tables 1 and 2 . Median age was 69 (interquartile range, 59-78) years and 55.8% patients were male. None of the continuous variables were normally distributed. One hundred seventy-seven patients (57.5%) received only intravenous r-tPA treatment, 30 patients (9.7%) received IAT (with or without intravenous r-tPA), and 101 patients (32.8%) did not receive either intravenous r-tPA or IAT (conservative group). Ninety-three patients had complete recanalization, and 91 patients had a persistent occlusion or partial recanalization at follow-up imaging. In 124 patients, no follow-up CTA images were available, and the recanalization could not be assessed. For the remaining patients, followup CTA was performed at an average of 3.0 (±1.5) days after admission.
For the perviousness assessment, 23 patients (7%) required manual correction after a suboptimal automatic image registration. 10 The median TAI was 20.1 (interquartile range, 8.5-37.8) Hounsfield unit (HU). TAI differed significantly for thrombus location in the anterior and in the posterior circulation and between IAT and no IAT subgroups. TAI was statistically significantly correlated with continuous National Institutes of Health Stroke Scale (NIHSS) and NCCT slice thickness (P<0.001 and P=0.02, respectively). Continuous NIHSS and time from symptom onset to image acquisition time were significantly associated with complete recanalization (P=0.032 and P=0.019, respectively). The distributions of the measured TAI per treatment group for primary and secondary outcomes are shown in Figure 2 .
Association of TAI With Complete Recanalization
In the univariate models, intravenous r-tPA was significantly associated with complete recanalization (OR, 2.93; 95% CI, 1.5-5.8; P=0.002), whereas TAI was not (P=0.63). In the multivariate model, we found a significant increase in the odds of complete recanalization for the interaction between TAI and intravenous r-tPA (P=0.037). In this model, the association of intravenous r-tPA and TAI with outcome were both nonsignificant (P=0.69 and P=0.20). mRS score: 0, no symptoms at all; 1, no significant disability despite symptoms; 2, slight disability; 3, moderate disability; 4, moderately severe disability; 5, severe disability; and 6, dead. Uncomplete recanalization shows no perfusion or penetration with reduced perfusion; complete recanalization shows complete filling/patency. ACA indicates anterior cerebral artery; HU, Hounsfield unit; IAT, intra-arterial treatment; ICA, intracranial cerebral artery; IQR, interquartile range; IV r-tPA, intravenous recombinant tissue-type plasminogen activator treatment; M1, sphenoidal segment of the middle cerebral artery; M2, insular segment of the middle cerebral artery; mRS, modified Rankin Scale; OR, odds ratio; PCA, posterior cerebral artery; and TAI, thrombus attenuation increase. *P<0.1. †P<0.05. 
Association of Dichotomized TAI With Complete Recanalization
In the intravenous r-tPA population, the area under the receiver operating curve predicting complete recanalization for various perviousness thresholds was 0.63. The optimal threshold for predicting recanalization was 23 HU (both sensitivity and specificity=0.63). The interaction plot displayed in Figure  3 illustrates the strong interaction between treatment and dichotomized perviousness. This plot indicates that the odds of complete recanalization after intravenous r-tPA is much higher for patients with a pervious thrombus (OR, 
Association of Dichotomized TAI With Functional Outcome
The OR for favorable outcome when having a pervious thrombus was 2.1 (95% CI, 1.3-3.4; P=0.001) for the whole population and 2.7 (95% CI, 1.43-5.0; P=0.002) for the intravenous r-tPA subgroup. In the multivariate model including perviousness and recanalization status, both dichotomized perviousness and recanalization status at 24 hours were significantly associated with favorable outcome with an aOR of 3.2 (95% CI, 1.4-7.3; P=0.007) and 2.9 (95% CI, 1.3-6.8; P=0.011), respectively, in the intravenous r-tPA group. This indicates that perviousness is associated with outcome independently of recanalization status. None of the aORs were significant in the conservative and in the IAT groups.
Discussion
Our results show that the efficacy of intravenous r-tPA, expressed both in rates of complete recanalization and functional outcome, was much higher in patients with a pervious thrombus. Furthermore, high thrombus perviousness, assessed on common radiological imaging in the acute stage of ischemic stroke, was also associated with better functional outcome in patients who did not receive treatment with intravenous r-tPA. Continued. the threshold used to dichotomize the thrombi as pervious or impervious. There was a significant difference in attenuation increase between complete and incomplete recanalized patients as assessed with the Mann-Whitney tests and the 1-way Kruskal-Wallis analysis of variance. B, Boxplot of the perviousness distribution for patients with unfavorable (modified Rankin Scale [mRS] score of >2) and favorable (mRS score of ≤2) functional outcome for the total population. There was a statistically significant difference in the perviousness between the 2 groups as assessed with the Mann-Whitney test. C, Boxplot of the perviousness distribution for favorable and unfavorable functional outcomes for the different treatments groups. There was a significant higher thrombus attenuation increase for the patients with favorable outcome in the intravenous recombinant tissuetype plasminogen activator treatment (IV r-tPA) and conservative treatment groups. IAT indicates intra-arterial treatment; and HU, Hounsfield unit. Our findings on the increased rate of intravenous r-tPAinduced recanalization with increasing perviousness is consistent with both preclinical 6 and clinical studies. [13] [14] [15] In a previous study using lysis modeling of fibrin thrombi with various permeability, it was demonstrated that lysis would require hundreds of minutes in impermeable thrombi. 6 Other studies demonstrated an association between success of recanalization after intravenous r-tPA and qualitative assessment of flow passing through a thrombus for both ischemic stroke and coronary occlusion. [13] [14] [15] Because perviousness increased the odds of recanalization, and recanalization is associated with improved functional outcome, it is not surprising that there is a direct relation between perviousness and favorable functional outcome in the intravenous r-tPA group. However, this association was still significant after adjusting for recanalization in a multivariate model. This implies that in addition to improving rates of recanalization, perviousness is also independently associated with improved functional outcome. Moreover, in patients who did not receive thrombolytic therapy, perviousness had a significant positive association with favorable outcome. This is consistent with a previously found association in a population with proximal occlusion of the anterior circulation 7 and supports the hypothesis that permeable thrombi allow passage of blood, and thereby enhance tissue oxygenation distally to the occlusion.
In our study, the optimum cut-off value for the dichotomizing perviousness is slightly higher than in a previous study. 7 This suggests that a higher permeability (higher TAI values) may be required to ensure complete recanalization after intravenous r-tPA than the permeability that is necessary to improve functional outcome. However, an assessment of the dependence of thresholds for different outcomes was beyond the scope of this study.
In the IAT group, only a limited amount of patients had a pervious thrombus. Patients who underwent IAT had a relative large thrombus load. Because of larger thrombi, it is likely that the contrast agent takes more time to pass through the thrombotic material.
We found that NIHSS was negatively correlated with TAI, which might imply that patients with a less neurological deficit on admission, in general, had a more pervious thrombus. To the best of our knowledge, this has never been reported before. 
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This study has several limitations. Recanalization status was assessed after ≈3 days, which can be considered late because early recanalization (within hours) is expected to have a strong effect on functional outcome. The patients categorized as recanalized may have had late, spontaneous, recanalization, which may have little or no effect on tissue salvage. Using 72 hours rather than early CTA for recanalization may have biased the analysis and may explain why perviousness is an independent predictor of outcome in a model that includes recanalization. We considered thrombi as homogeneous, and we used mean thrombus attenuations on CTA and NCCT as input value to determine perviousness. As variations exist within a thrombus, attenuation measurement of entire segmented thrombi could be more informative. 16 Also, CTA was used to assess contrast penetration in thrombi and is expected to be an accurate estimate of permeability. Yet, CTA could result in incomplete filling of the thrombus because of timing limitations, hemodynamic restrictions, or pseudo-occlusions, causing an underestimation of the potential maximal attenuation increase in CTA. 17, 18 For a more reliable measurement, thinly reconstructed dynamic CTA imaging 19, 20 could be a valuable alternative. Also, in this cohort, most CTA were acquired after CT perfusion scanning. It is therefore likely that some contrast from the CT perfusion acquisition remains in the thrombus at the time of the CTA acquisition. Therefore, it is possible that if CT perfusion is not included in the scan protocol as is now common practice, the contrast increase may be reduced. However, this dependency was previously studied 7 and no effect was found.
This study demonstrates that assessment of thrombus permeability on admission imaging is strongly associated with early recanalization after intravenous r-tPA. This thrombus perviousness biomarker would allow clinicians to make decisions favoring early intra-arterial thrombectomy in patients with a low likelihood of complete early recanalization with intravenous r-tPA. In addition, it can be used as a prognosticator for functional outcome in acute settings. However, it is much too early to recommend a threshold for which intravenous r-tPA should be bypassed because of a low probability of success.
Conclusions
We showed that thrombus permeability estimated from thrombus attenuation measurements on admission imaging strongly increases intravenous r-tPA efficacy and is associated with functional outcome. This suggests that this measure is a good candidate for patients with ischemic stroke stratification in the acute setting. Supplemental online Figure I . Inclusion Chart. Patient image and clinical data were retrospectively selected from the Dutch Acute Stroke Study (DUST) (n=1393), a prospective multicenter cohort study in patients with a clinical diagnosis of acute ischemic stroke who underwent CT-scanning within nine hours after symptom onset. We included patients with a proven proximal occlusion of the anterior or posterior circulation on CTA, (n=671). Three hundred and thirty-five patients were excluded because of image quality limitations: 189 had no thin-slice NCCT and an additional 12 had no thin slice CTA; 65 had movement artefacts on NCCT (n=47) or on CTA (n=18); 41 had an incomplete region of interest (24 for NCCT and 17 for CTA); 12 were extensively noisy on NCCT (n=7) or CTA (n=5); 11 CTAs were in venous phase; 4 had cerebrospinal fluid shunt induced artefacts and 1 NCCT was erroneously acquired after contrast agent administration. Three hundred and thirty-six patients were included for attenuation assessment from which 29 patients were excluded during the actual assessment because the thrombus was too small to be measured (n=19) or because of the proximity of multiple arteries or veins made assessment too difficult (n=7), because of calcifications (n=1), or because both ICAs were occluded (n=1), resulting in 308 patients that were finally included in this study. For 124 patients no follow-up images were available and the recanalization could not be assessed. ROI indicates region of interest; NCCT, non-contrast computed tomography image; CTA, computed tomographic angiography images; IV-rtPA, intravenous recombinant tissue-type plasminogen activator treatment; IAT, intra-arterial treatment; Legend: the right oriented arrow represents an exclusion, the plain down oriented arrow represents an inclusion.
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